Last reviewed · How we verify
NCT04377893
Applying Eye-Gaze Assistive Technology for Children and Youth With Complex Needs
NA trial testing Eye gaze AT intervention in Self-Help Devices in 5 participants. Completed in 31 July 2020.
31 July 2020
Quick facts
| Lead sponsor | Yu-Hsin Hsieh |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 5 |
| Start date | 19 September 2019 |
| Primary completion | 31 July 2020 |
| Estimated completion | 31 July 2020 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Eye gaze AT intervention
Conditions studied
- Self-Help Devices — all drugs for Self-Help Devices →
- Eye-Gaze Technology — all drugs for Eye-Gaze Technology →
- Severe Physical Disabilities — all drugs for Severe Physical Disabilities →
- Communication Disorders — all drugs for Communication Disorders →
Sponsor
Yu-Hsin Hsieh
Who can join
Adults 1 to 25, any sex, with Self-Help Devices or Eye-Gaze Technology. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research is to investigate the impacts of applying eye-gaze assistive technology (AT) in children and youth with severe disabilities and complex needs in Taiwan, where eye-gaze AT has not been researched for children yet.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04377893
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04377893 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yu-Hsin Hsieh
- Last refreshed: 27 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04377893.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing